US IPO Pipeline SEC S-1 Filings — May 20, 2026

20-05-2026

FutureCorp Space Acquisition 1 filed an S-1 registration statement on May 19, 2026, for an initial public offering of 20,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half of one redeemable warrant, aiming to raise $200,000,000. The blank check company has not yet selected a business combination target and has not initiated substantive discussions with any target. The offering includes a 45-day over-allotment option for up to 3,000,000 additional units, and the sponsor and underwriter have committed to purchase 6,000,000 private placement warrants at $1.00 per warrant, generating $6,000,000. However, the sponsor acquired 5,750,000 founder shares at a nominal price of $0.004 per share, resulting in immediate and substantial dilution for public shareholders, and the company has no identified target, introducing significant uncertainty.

• · The company is a blank check company incorporated in the Cayman Islands and has not selected any business combination target.
• · The warrants become exercisable 30 days after the initial business combination and expire five years after that combination.
• · Public shareholders have redemption rights at a per-share price equal to the trust account balance (less taxes) divided by outstanding public shares, but shareholders holding more than 15% of shares sold in the offering are restricted from redeeming more than 15% without prior consent.
• · Non-managing sponsor investors may purchase private placement warrants at $1.00 per warrant and receive founder shares at $0.004 per share, potentially realizing enhanced returns.
• · The underwriters receive upfront discounts and deferred underwriting commissions on units purchased by non-managing sponsor investors, if any.
• · The company will not use trust account proceeds to pay excise taxes under the Inflation Reduction Act of 2022.
• · The offering is subject to completion and the registration statement is not yet effective.

20-05-2026

Deep Fission, Inc. filed an S-1 registration statement on May 20, 2026, for an IPO of 6,000,000 shares of common stock at an anticipated price range of $24.00 to $26.00 per share. The company has applied to list on Nasdaq under the symbol 'FISN'.

• · The filing date is May 20, 2026.
• · The anticipated public offering price range is $24.00 to $26.00 per share.
• · The company is a Delaware corporation with principal executive offices in Berkeley, California.
• · The common stock has no established public trading market.

20-05-2026

Medline Inc., the largest provider of medical-surgical products and supply chain solutions, filed an S-1 registration statement on May 20, 2026, for a secondary offering of Class A common stock by selling stockholders. The company highlights a durable recurring revenue base with net sales growing at an 18% CAGR since inception, driven by its integrated Medline Brand and Supply Chain Solutions segments. However, the filing also notes that the IPO closed on December 18, 2025, and this offering involves the exchange of Common Units by existing pre-IPO owners, including Blackstone, Carlyle, H&F, and the Mills Family, which may signal partial exits by major investors.

• · The filing is for a secondary offering of Class A common stock by selling stockholders, not a primary issuance by the company.
• · The IPO of Medline Inc. closed on December 18, 2025, and this S-1 relates to a subsequent offering.
• · Pre-IPO owners include Principal Stockholders (Blackstone, Carlyle, H&F, Mills Family) and Other Pre-IPO Investors (Hux, Platinum Falcon).
• · The company operates 30 manufacturing facilities and 70 global distribution facilities.
• · Medline Brand segment offers approximately 190,000 products, while Supply Chain Solutions offers approximately 145,000 third-party products.
• · The company has a dedicated U.S. commercial team of approximately 4,000 people.
• · Underwriters have an option to purchase up to an additional 9,000,000 shares from selling stockholders.
• · The company was founded in 1966 and the Sponsor Acquisition occurred on October 21, 2021.

20-05-2026

Picard Medical, Inc. filed an S-1 registration statement for an IPO of up to $150M in common stock. For the year ended December 31, 2025, the company reported net state income tax benefits from Arizona and California, offset by current state income tax expense in California, New Jersey, and Texas. The filing includes detailed financial data for 2024 and 2025, with revenue breakdowns by product, rentals, and related services, as well as geographic and customer concentration risks.

• · The filing includes financial data for the years ended December 31, 2023, 2024, and 2025.
• · Revenue is broken down into product sales, rentals, and related services.
• · Geographic revenue concentration: US, Europe, and other foreign countries.
• · Customer concentration: Customer A, Customer B, Customer I are significant customers.
• · Accounts receivable concentration: Customer A, Customer B, Customer F, Customer H in 2025; Customer A, Customer E, Customer F in 2024.
• · The company has a senior secured note and warrant liabilities.
• · Property, plant, and equipment includes equipment, furniture and fixtures, leasehold improvements, and finance leases.
• · Intangible assets include developed technology rights, trade names, and licensing agreements.
• · The company has a reverse stock split effective July 11, 2025.
• · The company has a subsidiary in Beijing, China (Syncardia Medical Beijing) with noncontrolling interests.

20-05-2026

Space Exploration Technologies Corp. (SpaceX) filed an S-1 registration statement for an initial public offering of Class A common stock on Nasdaq under symbol SPCX. The offering size and price range are not yet disclosed. Elon Musk will retain majority voting control post-IPO through his ownership of Class B shares with 10 votes per share, making SpaceX a 'controlled company' exempt from certain governance rules. The filing includes retrospective financial recasts for the acquisitions of xAI and X Holdings, which were under common control.

• · The filing includes retrospective recast of financials for the xAI merger (effective Feb 2, 2026) and X Holdings merger (effective Mar 28, 2025), both under common control.
• · A five-for-one stock split of Class A, B, and C common stock was effective May 4, 2026, and all share/per share data are retroactively adjusted.
• · SpaceX has applied to list on both Nasdaq and Nasdaq Texas under symbol SPCX.
• · The underwriters have a 30-day option to purchase additional shares.
• · A directed share program reserves up to a certain percentage of shares for specified parties (details not disclosed).

20-05-2026

Skyworks Solutions, Inc. filed an S-4 registration statement on May 20, 2026, in connection with its proposed merger with Qorvo, Inc. The filing details exchange offers for up to $1,550,000,000 aggregate principal amount of Skyworks notes (4.375% Senior Notes due 2029 and 3.375% Senior Notes due 2031) to holders of Qorvo notes, contingent upon the consummation of the merger and other conditions. The exchange includes a Consent Payment of $2.50 per $1,000 principal and an Early Participation Premium of $50.00 per $1,000 principal in Skyworks notes, but the merger itself is subject to multiple closing conditions including stockholder approvals, antitrust clearance, and no material adverse effects.

• · Skyworks' key customers include Amazon, Apple, Cisco, Ericsson, Google, Samsung, and Tesla among others. Competitors include Broadcom, Qorvo (itself), Qualcomm, and Texas Instruments.
• · Qorvo is organized into three segments: High Performance Analog (HPA), Connectivity and Sensors Group (CSG), and Advanced Cellular Group (ACG).
• · The merger consideration consists of Skyworks common stock, and the issuance was approved by Skyworks stockholders on February 11, 2026.
• · The exchange offers are conditioned on the completion of the mergers, which cannot be waived by Skyworks.
• · The Proposed Amendments to the Qorvo Indentures require consent of holders of at least a majority in aggregate principal amount of each series of Qorvo Notes.
• · Consents cannot be revoked after the Consent Revocation Deadline, but Qorvo Notes can be withdrawn from the exchange offer until the Expiration Date.